The former Roche pharmaceutical boss will become the new CEO of Bayer.
(Photo: dpa)
Zurich, Dusseldorf “I couldn’t be happier to join Team Bayer.” That was the first message Bill Anderson shared on LinkedIn on Wednesday evening. On June 1st, the longstanding top manager of the Swiss pharmaceutical company Roche will take over the CEO position at the Leverkusen-based group. He will then replace Werner Baumann as CEO after nine years.
Anderson will join Bayer’s board of directors in April. The American is only the second boss in the history of the Leverkusen team who is not recruited from within their own ranks – and the first who does not speak fluent German. But that was not an obstacle, according to Bayer circles. A globally experienced manager with proven expertise in biotechnology was deliberately selected. This is crucial for further development in medicine and in agricultural chemistry.
Read on now
Get access to this and every other article in the
Web and in our app free of charge for 4 weeks.
Further
Read on now
Get access to this and every other article in the
Web and in our app free of charge for 4 weeks.
Further